In Vitro Diagnostics (IVD) Market Effect and Growth Factors Research and Projection 2018-2026

In vitro diagnostics
are diagnostic devices and equipment that extract vital information
about an individual or patient after a sequence of tests.
Introduction of novel diagnostics test applications on the backdrop
of advancements and innovations in the IVD technologies by various
organizations has resulted in rampant growth of the in vitro
diagnostics (IVD) market, which is expected to sustain in the near
future. Diagnoses and tests are precursors to any treatment, which
makes in vitro diagnostic market highly lucrative. However, majority
of the tests are remotely performed making their presence and use
unnoticed. Furthermore, increasing elderly population base and rising
demand for diagnostic testing is projected to spur growth of the in
vitro diagnostics (IVD) market over the forecast period (2016–2024).
Also, growing prevalence of diabetes has increased the demand for in
vitro diagnostic tests in the recent past, which is further expected
to add on to the sales revenue of the in vitro diagnostic market. In
2014, as per National Diabetes Statistics Report 2014, around 9.3% of
the population in the U.S. suffered from diabetes and around 28.0%
were undiagnosed.
Get Exclusive
Sample Report at: http://bit.ly/2RI9PmM
Market Dynamics
Rapid strides made
in technology and inclination of healthcare providers towards
expanding their product portfolio is fueling growth of this highly
lucrative market, especially in emerging economies, which are largely
untapped. Furthermore, rise in prevalence of infectious disease
globally, especially in Asia Pacific would inadvertently support
market growth in the near future. Major organizations in the in vitro
diagnostic market are actively focusing on introducing novel
technologies in the testing and diagnostic segments of molecular
biology. Such initiatives are projected to bring about a rapid shift
in the dynamics of in vitro diagnostics (IVD) market, with Asia
Pacific taking on the mantle from North America to emerge as the
largest market for in vitro diagnostics, owing to latest technologies
and uninterrupted investment in the health care sector is expected
further to support the growth in in vitro diagnostic market in the
near future.
Infectious
diseases segment accounted for the highest revenue in the in-vitro
diagnostics market
Among application,
infectious diseases segment accounted for the highest revenue in the
in-vitro diagnostics (IVD) market. The segment is expected to grow by
1.5X at a CAGR of 4.4% between 2016 and 2024. The prevalence of
infectious diseases has increased considerably over the past few
years. In 2016, morbidity cases in tuberculosis, salmonella and
meningococcal disease was as high as 90,000 in the U.S. These factors
have led to increasing demand for IVD from diagnostic centers,
thereby driving growth of the market. As per the Centers for Disease
Control and Prevention (CDC), over 3.9 million patients visited
hospital outpatient department for infectious and parasitic diseases.
The demand for IVD is expected to increase, as it is largely used for
the detection of autoimmune disorders and infectious diseases.
North America is
expected to dominate the market revenue throughout the forecast
period
North America is
highest contributing region for In vitro diagnostics (IVD) market,
with a projected market share of 46.7% by 2024, expanding at the
fastest CAGR of 5.4% between 2016 and 2024. Changing healthcare
landscape, favorable regulatory policies such as Medicaid and
Medicare along with significant healthcare spending (16.7%) is
expected to boost the market for IVD in the region. Though the market
outlook seems lucrative in North America, reimbursement pressure,
increased usage of companion diagnostic and significant growth
potential of next generation sequencing (NGS) are key challenges for
the industry players in the North America. Companion diagnostics
market is proliferating at faster market pace compared to IVD. As
such, product innovation in the segment is the key focus area for
market players. North America has also seen some of the major mergers
and acquisitions in the recent past, to tap into market
opportunities. For instance, Roche acquired Ventana Medical in 2008.
In 2011, Novartis acquired Genoptix to capture a greater chunk of
market in the U.S.
Ask For Discount
Before Purchasing This Business Report @ http://bit.ly/2KJ2rXu
Market players
need to invest in R&D and follow inorganic growth to generate
high ROI in longer run
Market players are
focused towards research and development to expand their business
reach in the market. Moreover, industry players are focused towards
generating revenue from respective key product segment. For instance,
while Roche and Siemens are active players in clinical chemistry IVD
product segment, Allere and Abbott holds key market share in point of
care IVD solutions. Furthermore, the In vitro diagnostics (IVD)
market is expected to witness mergers and acquisition in near future,
wherein leading players are expected to acquire regional companies
based in emerging economies. Similar trends have been noticed in
recent past where leading players acquired/partnered with regional
players. For instance, Roche acquired majority stake in Foundation
medicine with US$ 1.2 Bn in 2015.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment